Abstract Because glycogen synthase kinase-3 (GSK-3) activity is linked to various human diseases, it has been targeted in new drug development. Flavonoids, including luteolin, apigenin, and quercetin, inhibit GSK-3b; however, the relationships between their structural properties and inhibitory effects are unclear. We measured the inhibitory effects of 34 flavonoid derivatives on GSK-3b and calculated hologram quantitative structure-activity relationships to provide information on pharmacophores for designing novel compounds with better activities. The in vitro binding effect of flavonoids was confirmed using Western blotting for myricetin, which showed the best inhibitory activity, and the binding mode between myricetin and GSK-3b was elucidated using in silico docking.
Introduction
Since the identification of glycogen synthase kinase-3 (GSK-3), its cellular multi-functions, including cell proliferation, apoptosis, and development, have been identified [1] . Because the activity of GSK-3 is linked to various human diseases such as neurodegenerative disorders, inflammation, and diabetes, it has been targeted in the development of new drugs [2] . The first GSK-3b inhibitor was lithium ion, which enhances serine phosphorylation and competes with magnesium ion [3] [4] [5] . Its half-maximal inhibitory concentration (IC 50 ) is 1-2 mM [4] . Staurosporine isolated from Streptomyces staurosporeus is a potent GSK-3b inhibitor (IC 50 = 15 nM) [6] . Flavonoids have been reported to have inhibitory effects on GSK-3b [7] . Although the inhibitory effects of several flavonoids against GSK-3b have been tested [8] , the relationships between their structural properties and inhibitory effects have not been reported. Quantitative structure-activity relationships (QSARs) can provide information on pharmacophores for designing novel compounds with better activities. Even the data reported previously contained the IC 50 values of several citrus flavonoids [8] ; we tested the inhibitory effects of 34 flavonoid derivatives on GSK-3b here. The hologram QSARs (HQSARs) could be calculated in this work. The aim of this study is to identify the structural conditions of flavonoids that can enhance the inhibitory effects on GSK-3b. To confirm the in vitro binding effect of flavonoids, Western blot analysis was carried out for myricetin, which showed the best inhibitory activity in this research, and in silico docking was performed to elucidate the binding mode between myricetin and GSK-3b.
Materials and methods
The 34 flavones tested here included 13 hydroxyflavones, two methoxyflavone, five hydroxymethoxyflavones, and 14 glycosylated flavones (Table S1 ). All compounds were Electronic supplementary material The online version of this article (doi:10.1007/s13765-017-0271-2) contains supplementary material, which is available to authorized users.
used without further purification, and their purities were determined using high-performance liquid chromatography [9] .
The GSK-3b kinase assay was carried out using the EMD Millipore KinaseProfiler service assay protocol (EMD Millipore Corp., Billerica, MA, USA). GSK-3b was supplied by EMD Millipore Corp. GSK-3b was incubated with 8 mM 3-(N-morpholino)propanesulfonic acid buffer (pH 7.0), 0.2 mM ethylenediaminetetraacetic acid, 20 lM substrate for phosphorylation (YRRAAVPPSPSLSRHSSPHQS), 10 mM Mg acetate, and 10 lM ATP. The specific activity of 33P-ATP was adjusted to approximately 500 cpm/pM. The magnesium-ATP mixture was added for the initiation of the enzyme reaction. The incubation was performed for 40 min at room temperature. And, 3% phosphoric acid was added for the stop of the reaction. Ten lL of the reaction solution was spotted on a P30 filtermat (PerkinElmer, London, UK). It was washed with 50 mM phosphoric acid three times and with methanol once. It was dried for scintillation counting [10, 11] . All experiments were repeated three times at five different concentrations (0, 5, 10, 20, and 40 lM). The IC 50 values were obtained using SigmaPlot software (Systat, Chicago, IL, USA). The sigmoid curve fit method was used. The negative logarithmic values (pIC 50 ) were used as the biological data for the HQSAR calculations (Table S1 ) [12] . The procedures for HQSAR calculations followed the method reported previously [9, 13] .
HCT116 cells were either left untreated or treated with 30 mM LiCl in the absence or presence of different concentrations of myricetin. After the indicated time periods, cell lysates containing 20 lg protein were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. The blots were probed with an antibody against phospho-GSK-3b (Ser9; Cell Signaling Technology, Danvers, MA, USA; 1:1000) for 4 h, followed by incubation with a secondary antibody conjugated to horseradish peroxidase for 2 h, as described previously [13] . Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control. The results were visualized using an enhanced chemiluminescence detection system (GE Healthcare, Piscataway, NJ, USA). The relative band intensities were measured with a quantitative scanning densitometer and image analysis software, Bio-1D ver 97.04 (Froebel, Wasserburg, Germany).
The three-dimensional (3D) structure of myricetin was obtained from the crystal structure deposited in the protein data bank (PDB) as a complex with human pancreatic alpha-amylase (4gqr.pdb) [14] . Human GSK-3b consists of 420 amino acids. Sixty-nine 3D structures of human GSK3b are deposited in the PDB. All of these structures were determined using X-ray crystallography. Because staurosporine isolated from Streptomyces staurosporeus is known to be a representative GSK-3b inhibitor, the crystallographic structure (1q3d.pdb) containing staurosporine as a ligand was chosen [15] . In silico docking experiments followed the method reported previously [11] . The structure of 1q3d.pdb consists of two chains, A and B. Chain A was used because its structure includes two more residues than chain B. The 3D structure of 1q3d-A is composed of 35-119, 126-286, and 293-385 residues. The apo-protein of 1q3d-A was prepared using the Sybyl program. To obtain the solution structure of the apo-GSK-3b protein, energy minimization was performed according to a method reported previously [12] . The superposed result between apo-1q3d-A and the crystallographic structure deposited in the PDB produced a root-mean-square standard value of 0.29 Å . The binding site of the substrate was determined using the LigPlot program and consisted of the following: Ile62, Gly63, Gly65, Val70, Ala83, Leu132, Asp133, Tyr134, Val135, Gln185, Asn186, Leu188, Cys199, and Asp200. The flexible docking method used the Sybyl program, and the details of this method have been reported previously [12] . To confirm that this docking method was working well, an original ligand, staurosporine, was docked to apo-1q3d-A. Of the 30 complexes of staurosporine and 1q3d-A generated from the 30 iterations, the 5th complex showed the best docking pose and its binding energy was -16.67 kcal/mol. Ten hydrophobic interactions (Ile62, Ala83, Lys85, Leu132, Tyr134, Gln185, Asn186, Leu188, Cys199, and Asp200) and two hydrogen bonds (H-bonds, Asp133 and Val135) were observed in the complex based on the LigPlot analysis (Fig. S5) . Statistical significance was analyzed using Student's t test. A p value of less than 0.05 was considered statistically significant. All experiments were performed in triplicate [16] .
Results and discussion
The hologram QSAR (HQSAR) studies generate fragmentbased structure-activity relationships using molecular holograms [17] . The IC 50 values on GSK-3b of the 34 flavonoid derivatives ranged from 0.90 lM (8, myricetin) to 98.73 lM (20, apigetrin) (Fig. S1 ). The flavonoid derivatives used here consist of 14 glycosylated flavones and 20 aglycons (Table S1 ). The biological data for the HQSAR calculations were the negative logarithmic IC 50 (pIC 50 ) values, as listed in Table S1 . The derivatives were divided into a training set and a test set. The former was prepared to build up the HQSAR models, and the latter was used to validate the models. For the test set, six derivatives, 3, 6, 7, 11, 12, and 26, were selected arbitrarily. This selection was validated using hierarchical clustering analysis (HCA) [18] . The HCA results obtained from the Sybyl 7.3 program (Tripos, St. Louis, MO, USA) indicated that the six derivatives are not structurally similar derivatives, as shown in Fig. S2 .
HQSAR calculations were carried out using the QSAR/ HQSAR module provided by Sybyl 7.3. The hologram lengths were set to 53, 59, 61, 71, 83, 97, 151, 199, 257, 307, 353, and 401, which were provided as default values in the Sybyl 7.3 program. The fragment sizes ranged between 4 and 7. Fifteen HQSAR models were generated based on the influence of the fragment distinction in terms of atom (A), bond (B), connections (C), hydrogen atoms (H), chirality (Ch), and donor, and acceptor (DA), as listed in Table S2 . Because the fragment distinction including A, B, and DA and the fragment distinction including A, B, Ch, and DA showed good cross-validated correlation coefficient (q 2 ) values, 0.519 and 0.446, respectively, 12 models were generated for each fragment distinction using six different fragment sizes, 2-5, 3-6, 4-7, 5-8, 6-9, and 7-10, as listed in Table S3 . Although for the fragment distinction including A, B, and DA the variation of the fragment size did not improve the q 2 value, for the fragment distinction including A, B, Ch, and DA, the model with a fragment size of 5-8 or 7-10 increased the q 2 value to 0.556 or 0.661, respectively. The residual values between the experimental data and the values predicted by the HQSAR model using a fragment size of 5-8 showed better results than those using a fragment size of 7-10. Therefore, the HQSAR model with the fragment distinction of A, B, Ch, and DA and the fragment size of 5-8 was chosen. Its statistical parameters are as follows: cross-validated correlation coefficient (q 2 ), 0.566; non-cross-validated correlation coefficient (r 2 ), 0.942; standard error of estimate, 0.163; hologram length, 61; and optimal number of components (N), 6 [19] . The pIC 50 values calculated using this HQSAR model are listed in Table S4 . The experimental data were plotted against the values predicted by this HQSAR model (Fig. S3) . Its Pearson R correlation coefficient was 0.9403. The residuals between the experimental pIC 50 values and the predicted pIC 50 values were obtained. The residuals for the training set ranged from 0.12% to 21.26%, and for the test set, they ranged from 4.07% to 21.21%. As a result, this HQSAR model is reliable and can be used for the development of novel GSK-3b inhibitors.
To visualize the results obtained from the HQSAR calculations, contribution maps were generated using the Sybyl program. Positive, neutral, and negative contributions are expressed in green, white, and red colors, respectively. In the case of 3,3 0 ,4 0 ,5,5 0 ,7-hexahydroxyflavone (8, myricetin), which showed the best activity, hydroxyl groups at the meta and para positions of the B-ring are shown in green (Fig. 1A) . This figure demonstrates that the electronegative fragments of the m-, p-positions of the B-ring increase the inhibitory effects on GSK-3b. The bulky fragment at the 7-position of apigenin-7-O-glucoside (20, apigetrin) , which showed the worst activity, negatively affects the inhibitory activity (Fig. 1B) . The bulky fragments at the 6-position of the A-ring of 5-hydroxy-3 0 ,4 0 ,5 0 ,6,7,8-hexamethoxyflavone (16, gardenin) and at the 3-position of the B-ring of myricetin-3-O-rhamnoside (30, myricitrin) also negatively affect the inhibitory activity (Figs. 1C, D) . These findings provide information about the structural conditions of flavonoids that can enhance the inhibitory effects on GSK-3b.
Myricetin, which had the best inhibitory effect on GSK3b, is found in various plants such as tea, vegetables, fruits, and berries [20] . Its antioxidative and anticancer activities have been studied thoroughly [20, 21] . However, its inhibitory effect on GSK-3b has not been reported. Unlike most protein kinases, GSK-3b is active in resting conditions and is inactivated by cellular responses. The activity of GSK-3b is negatively regulated by phosphorylation at the serine-9 residue in its regulatory N-terminal region [22] . Thus, increased phosphorylation of this serine-9 residue in GSK-3b is functionally associated with the inhibition of its kinase activity. To confirm the result obtained from the in vitro GSK-3b kinase assay, HCT116 human colon cancer cells were treated with different concentrations of myricetin, and the phosphorylation status at serine-9 was then assessed by Western blot analysis using a phosphospecific antibody. Lithium, a known GSK-3b inhibitor, was used as a reference compound. The level of serine-9 phosphorylation of GSK-3b increased rapidly within 30 min after LiCl treatment ( Fig. 2A) , indicating the rapid inactivation of GSK-3b by lithium. HCT116 cells were then treated with different concentrations (20, 40 , and 80 lM) of myricetin for 30 min, and we measured the serine-9 phosphorylation of GSK-3b (Fig. 2B) . Densitometric analysis demonstrated that myricetin caused an increase in the level of serine-9 phosphorylation of GSK3b in a dose-dependent manner. As a result, the data obtained here suggest that the binding of myricetin to GSK-3b is associated with the inhibition of GSK-3b activity.
To elucidate the molecular binding mode between myricetin and GSK-3b, in silico docking analysis was carried out. Among sixty-nine 3D structures of human GSK-3b deposited in the PDB, the crystallographic structure (1q3d.pdb) containing staurosporine (Fig. S4) as a Fig. 2 Effect of myricetin on the serine-9 phosphorylation of GSK-3b. (A) HCT116 cells were serum-starved for 24 h, and 30 mM LiCl was then added for various time periods. Whole lysates were prepared, and western blot analysis was performed using a phosphospecific antibody against serine-9 of GSK-3b. GAPDH was used as an internal control. (B) HCT116 cells were serum-starved for 24 h, and 30 mM LiCl or different concentrations (20, 40 , and 80 lM) of myricetin were added for 30 min. Whole lysates were prepared, and western blot analysis was performed as in (A). The phosphorylated levels at serine-9 of GSK-3b were quantified using densitometry, and the results are shown as the fold change compared to unstimulated control cells (Cont). GAPDH was used as an internal control ligand was chosen [15] . This structure consists of two chains, A and B. Chain A was used because its structure includes two more residues than chain B. First, the ligand contained in 1q3d.pdb, staurosporine, was docked into the apo-GSK-3b protein (1q3d-A). The 5th complex showed the best binding pose, and its binding energy was -16.67 kcal/mol. Ten hydrophobic interactions and two hydrogen bonds (H-bonds) were observed in the LigPlot analysis (Fig. S5) . Next, Myricetin was docked to apo1q3d-A. Among the 30 complexes of myricetin and 1q3d-A generated from the 30 iterations, the second complex showed the best docking pose and lowest binding energy (-17 .87 kcal/mol). The LigPlot analysis revealed five hydrophobic interactions (Ile62, Val70, Ala83, Leu132, and Leu188) and four H-bonds (Asp133, Tyr134, and Val135) (Fig. S6) . To compare the binding conditions of myricetin to GSK-3b with those of staurosporine, 3D images of the binding sites were generated using the PyMOL program (The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC). In the complex of myricetin docked to GSK-3b, four H-bonds were observed, which are expressed as yellow dot circles (Fig. 3A) . The distances between the oxygen in the ketone of Asp133 and the hydrogen in the 5-hydroxyl group of myricetin, the oxygen of the hydroxyl group of Tyr134 and the hydrogen of the 3 0 -hydroxyl group of myricetin, the hydrogen of the amide of Val135 and the oxygen of the ketone in myricetin, and the oxygen of the ketone of Val135 and the hydrogen of the 3-hydroxyl group of myricetin were 2.93, 3.09, 2.81, and 2.03 Å , respectively. In the case of staurosporine, two H-bonds were observed (Fig. 3B) . The distances between the oxygen of the ketone of Asp133 and the hydrogen of the nitrogen of the pyrrolone of staurosporine and between the hydrogen of the amide of Val135 and the oxygen of the ketone of the pyrrolone of staurosporine were 2.62 and 3.01 Å , respectively. The interactions between myricetin and the binding site of GSK-3b were better than those between staurosporine and GSK-3b. These results may explain why the binding energy of myricetin is lower than that of staurosporine.
Luteolin abolishes GSK-3 activation [23] . Apigenin induces cell death by inhibition of GSK-3b in BxPC-3 and PANC-1 human pancreatic cancer cells [24] . Pretreatment of BxPC-3 human pancreatic cancer cells with luteolin and apigenin inhibits cell proliferation by reducing the expression of GSK-3b [24] . The inhibitory effects of 22 flavonoids were measured using the Kinase-Glo Luminescent Kinase Assay. Of these flavonoids, luteolin, apigenin, and quercetin showed good IC 50 values of 1.5, 1.9, and 2.0 lM, respectively [8] . In the paper published previously [8] , the IC 50 values of several flavonoids showed several tens of micromolar level and others were over hundreds of micromolar level, so that they could not obtain the structure-activity relationships (SAR) data quantitatively. Since the IC 50 values of 34 flavonoids tested here ranged between 0.9 and 98 lM, however, we could obtain the SAR data quantitatively. While the electronegative fragments of the m-, p-positions of the B-ring increase the inhibitory effects on GSK-3b, the bulky fragments at the 6-and 7-positions of the A-ring and at the 3-position of the B-ring negatively affect the inhibitory activity. While the paper published previously focused on in silico experimental results, the current results showed in vitro biological data including Western blot analysis as well as in silico Fig. 3 (A) 3D image of the binding site surrounding myricetin docked to GSK-3b generated using the PyMOL program and (B) that surrounding staurosporine docked to GSK-3b experimental results. In addition, the structural conditions of flavonoids that enhance the inhibitory effects on GSK3b were identified using hologram QSAR calculations. These findings will help in the development of novel GSK3b inhibitors.
